TABLE 1-A1.
Variable | HIV-uninfected N = 114 | HIV-infected N = 114 | p |
---|---|---|---|
Cardiovascular measurements | |||
SBP, mmHg | 133 ± 23.5 | 127 ± 23.5 | 0.057 |
DBP, mmHg | 87 ± 13.2 | 83 ± 13.2 | 0.029 |
PP, mmHg | 46 ± 14.6 | 43 ± 14.6 | 0.278 |
MAP, mmHg | 102 ± 15.9 | 97 ± 15.9 | 0.032 |
cSBP, mmHg | 128 ± 18.7 | 121 ± 18.9 | 0.004 |
Biochemical variables | |||
TC, mmol/L | 4.49 ± 11.9 | 4.56 ± 11.9 | 0.645 |
LDL-c, mmol/L | 2.72 ± 16.4 | 2.74 ± 16.4 | 0.911 |
TG, mmol/L | 1.12 (1.02; 1.23) | 1.15 (1.05; 1.27) | 0.642 |
HDL-c, mmol/L | 1.29 (1.21; 1.38) | 1.27 (1.20; 1.36) | 0.731 |
TG/HDL-C ratio | 0.87 (0.76; 0.98) | 1.10 (0.80; 1.03) | 0.603 |
Glucose, mmol/L | 5.23 (5.01; 5.47) | 5.22 (4.50; 5.43) | 0.937 |
HbA1c, % | 5.84 (5.68; 6.00) | 5.53 (5.38; 5.68) | 0.007 |
CRP, mg/L | 0.99 (0.67; 1.49) | 1.54 (1.03; 2.30) | 0.146 |
Renal markers | |||
CrCl, mL/min | 109 (104; 114) | 105 (100; 110) | 0.304 |
eGFR, mL/min/1.73 m2 | 102 (101; 106) | 103 (100; 105) | 0.573 |
uACR, mg/mmol | 1.50 (1.21; 1.87) | 1.80 (1.44; 2.24) | 0.270 |
Data are adjusted means ± SD or -95% and +95% CI for logarithmically transformed variables. SD, standard deviation; CI, confidence interval; HIV, human immunodeficiency virus; N, number of participants; DBP, diastolic blood pressure; SBP, systolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; cSBP, central systolic blood pressure; TC, total cholesterol; LDL-cholesterol, low density lipoprotein cholesterol; HDL-cholesterol, high-density lipoprotein cholesterol; TG:HDL-C, triglycerides: High-density lipoprotein cholesterol; CRP, C-reactive protein; CrCl, creatinine clearance; eGFR, estimated glomerular filtration rate; uACR, urinary albumin-creatinine ratio.